-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, M6owbYIHncqtUzK1WhVyb9RVuaP43rwD8eOqI5/5vDnepPyrijR0sCqFyF9BFKR0 wk5Jy5rgGMki1yGrVQDchQ== 0000912057-00-004445.txt : 20000209 0000912057-00-004445.hdr.sgml : 20000209 ACCESSION NUMBER: 0000912057-00-004445 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000208 GROUP MEMBERS: ALAN G. WALTON GROUP MEMBERS: CORNELIUS T. RYAN GROUP MEMBERS: EDMUND M. OLIVIER GROUP MEMBERS: JONATHAN J. FLEMING GROUP MEMBERS: OBP MANAGEMENT (BERMUDA)II LTD. GROUP MEMBERS: OBP MANAGEMENT II L.P. GROUP MEMBERS: OBP MANAGEMENT(BERMUDA)II LIMITED PARTNERSHIP GROUP MEMBERS: OXFORD BIOSCIENCE PARTNERS II L P GROUP MEMBERS: OXFORD BIOSCIENCE PARTNERS(ADJUNCT) II L.P. GROUP MEMBERS: OXFORD BIOSCIENCE PARTNERS(GS-ADJUNCT) II L.P. GROUP MEMBERS: OXFORD BIOSCIENCE PARTNETS(BERMUDA)II LIMITED PARTNERSHIP SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INKINE PHARMACEUTICAL CO INC CENTRAL INDEX KEY: 0000929547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133754005 STATE OF INCORPORATION: NY FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-47845 FILM NUMBER: 526895 BUSINESS ADDRESS: STREET 1: 1720 WALTON RD STREET 2: SUITE 200 CITY: BLUE BELL STATE: PA ZIP: 19422 BUSINESS PHONE: 6102609350 MAIL ADDRESS: STREET 1: 1720 WALTON RD STREET 2: SUITE 200 CITY: BLUE BELL STATE: PA ZIP: 19422 FORMER COMPANY: FORMER CONFORMED NAME: PANAX PHARMACEUTICAL CO LTD DATE OF NAME CHANGE: 19940906 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: OXFORD BIOSCIENCE PARTNERS II L P CENTRAL INDEX KEY: 0001022420 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 061460505 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: C/O OXFORD BIOSCIENCE PARTNERS STREET 2: 31 ST. JAMES AVE SUITE 570 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6173577474 MAIL ADDRESS: STREET 1: OXFORD BIOSCIENCE PARTNERS STREET 2: 31 ST. JAMES AVE SUITE 570 CITY: BOSTON STATE: MA ZIP: 02116 SC 13G/A 1 SCH13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 1)* INKINE PHARMACEUTICAL COMPANY, INC. (Name of Issuer) COMMON STOCK, $.0001 PAR VALUE (Title of Class of Securities) 457214 10 4 (CUSIP Number) DECEMBER 31, 1999 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: / / Rule 13d-1(b) / / Rule 13d-1(c) /X/ Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 19 pages CUSIP No. 457214 10 4 13G Page 2 of 19 pages - ------- ------------------------------------------------------------------------ 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Oxford Bioscience Partners II L.P. - ------- ------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) / / (b) / / - ------- ------------------------------------------------------------------------ 3 SEC USE ONLY - ------- ------------------------------------------------------------------------ 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - ------------------------- ----- ------------------------------------------------ 5 SOLE VOTING POWER 0 Shares NUMBER OF ----- ------------------------------------------------ SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 2,134,615 Shares ----- ------------------------------------------------ EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 0 Shares ----- ------------------------------------------------ WITH: 8 SHARED DISPOSITIVE POWER 2,134,615 Shares - ------- ------------------------------------------------------------------------ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,134,615 Shares - ------- ------------------------------------------------------------------------ 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / / - ------- ------------------------------------------------------------------------ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.3% - ------- ------------------------------------------------------------------------ 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - ------- ------------------------------------------------------------------------ Page 2 of 19 pages CUSIP No. 457214 10 4 13G Page 3 of 19 pages - ------- ------------------------------------------------------------------------ 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Oxford Bioscience Partners (Adjunct) II L.P. - ------- ------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) / / (b) / / - ------- ------------------------------------------------------------------------ 3 SEC USE ONLY - ------- ------------------------------------------------------------------------ 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - ------- ------------------------------------------------------------------------ 5 SOLE VOTING POWER 0 Shares NUMBER OF ----- ------------------------------------------------ SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 2,134,615 Shares ----- ------------------------------------------------ EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 0 Shares ----- ------------------------------------------------ WITH: 8 SHARED DISPOSITIVE POWER 2,134,615 Shares - ------------------------- ----- ------------------------------------------------ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,134,615 Shares - ------- ------------------------------------------------------------------------ 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / / - ------- ------------------------------------------------------------------------ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.3% - ------- ------------------------------------------------------------------------ 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - ------- ------------------------------------------------------------------------ Page 3 of 19 pages CUSIP No. 457214 10 4 13G Page 4 of 19 pages - ------- ------------------------------------------------------------------------ 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Oxford Bioscience Partners (GS-Adjunct) II L.P. - ------- ------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) / / (b) / / - ------- ------------------------------------------------------------------------ 3 SEC USE ONLY - ------- ------------------------------------------------------------------------ 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - ------- ------------------------------------------------------------------------ 5 SOLE VOTING POWER 0 Shares NUMBER OF ----- ------------------------------------------------ SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 2,134,615 Shares ----- ------------------------------------------------ EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 0 Shares ----- ------------------------------------------------ WITH: 8 SHARED DISPOSITIVE POWER 2,134,615 Shares - ------------------------- ----- ------------------------------------------------ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,134,615 Shares - ------- ------------------------------------------------------------------------ 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / / - ------- ------------------------------------------------------------------------ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.3% - ------- ------------------------------------------------------------------------ 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - ------- ------------------------------------------------------------------------ Page 4 of 19 pages CUSIP No. 457214 10 4 13G Page 5 of 19 pages - ------- ------------------------------------------------------------------------ 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) OBP Management II L.P. - ------- ------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) / / (b) / / - ------- ------------------------------------------------------------------------ 3 SEC USE ONLY - ------- ------------------------------------------------------------------------ 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - ------------------------- ----- ------------------------------------------------ 5 SOLE VOTING POWER 0 Shares NUMBER OF ----- ------------------------------------------------ SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 2,134,615 Shares ----- ------------------------------------------------ EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 0 Shares ----- ------------------------------------------------ WITH: 8 SHARED DISPOSITIVE POWER 2,134,615 Shares - ------------------------- ----- ------------------------------------------------ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,134,615 Shares - ------- ------------------------------------------------------------------------ 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / / - ------- ------------------------------------------------------------------------ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.3% - ------- ------------------------------------------------------------------------ 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - ------- ------------------------------------------------------------------------ Page 5 of 19 pages CUSIP No. 457214 10 4 13G Page 6 of 19 pages - ------- ------------------------------------------------------------------------ 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Oxford Bioscience Partners (Bermuda) II Limited Partnership - ------- ------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) / / (b) / / - ------- ------------------------------------------------------------------------ 3 SEC USE ONLY - ------- ------------------------------------------------------------------------ 4 CITIZENSHIP OR PLACE OF ORGANIZATION Bermuda - ------------------------- ----- ------------------------------------------------ 5 SOLE VOTING POWER 0 Shares NUMBER OF ----- ------------------------------------------------ SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 2,134,615 Shares ----- ------------------------------------------------ EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 0 Shares ----- ------------------------------------------------ WITH: 8 SHARED DISPOSITIVE POWER 2,134,615 Shares - ------------------------- ----- ------------------------------------------------ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,134,615 Shares - ------- ------------------------------------------------------------------------ 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / / - ------- ------------------------------------------------------------------------ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.3% - ------- ------------------------------------------------------------------------ 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - ------- ------------------------------------------------------------------------ Page 6 of 19 pages CUSIP No. 457214 10 4 13G Page 7 of 19 pages - ------- ------------------------------------------------------------------------ 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) OBP Management (Bermuda) II Limited Partnership - ------- ------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) / / (b) / / - ------- ------------------------------------------------------------------------ 3 SEC USE ONLY - ------- ------------------------------------------------------------------------ 4 CITIZENSHIP OR PLACE OF ORGANIZATION Bermuda - ------------------------- ----- ------------------------------------------------ 5 SOLE VOTING POWER 0 Shares NUMBER OF ----- ------------------------------------------------ SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 2,134,615 Shares ----- ------------------------------------------------ EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 0 Shares ----- ------------------------------------------------ WITH: 8 SHARED DISPOSITIVE POWER 2,134,615 Shares - ------------------------- ----- ------------------------------------------------ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,134,615 Shares - ------- ------------------------------------------------------------------------ 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / / - ------- ------------------------------------------------------------------------ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.3% - ------- ------------------------------------------------------------------------ 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - ------- ------------------------------------------------------------------------ Page 7 of 19 pages CUSIP No. 457214 10 4 13G Page 8 of 19 pages - ------- ------------------------------------------------------------------------ 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) OBP Management (Bermuda) II Ltd. - ------- ------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) / / (b) / / - ------- ------------------------------------------------------------------------ 3 SEC USE ONLY - ------- ------------------------------------------------------------------------ 4 CITIZENSHIP OR PLACE OF ORGANIZATION Bermuda - ------- ------------------------------------------------------------------------ 5 SOLE VOTING POWER 0 Shares NUMBER OF ----- ------------------------------------------------ SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 2,134,615 Shares ----- ----------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 0 Shares ----- ------------------------------------------------ WITH: 8 SHARED DISPOSITIVE POWER 2,134,615 Shares - ------------------------- ----- ------------------------------------------------ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,134,615 Shares - ------- ------------------------------------------------------------------------ 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / / - ------- ------------------------------------------------------------------------ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.3% - ------- ------------------------------------------------------------------------ 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO - ------- ------------------------------------------------------------------------ Page 8 of 19 pages CUSIP No. 457214 10 4 13G Page 9 of 19 pages - ------- ------------------------------------------------------------------------ 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Edmund M. Olivier - ------- ------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) / / (b) / / - ------- ------------------------------------------------------------------------ 3 SEC USE ONLY - ------- ------------------------------------------------------------------------ 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - ------- ------------------------------------------------------------------------ 5 SOLE VOTING POWER 0 Shares NUMBER OF ----- ------------------------------------------------ SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 2,134,615 Shares ----- ------------------------------------------------ EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 0 Shares ----- ------------------------------------------------ WITH: 8 SHARED DISPOSITIVE POWER 2,134,615 Shares - ------------------------- ----- ------------------------------------------------ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,134,615 Shares - ------- ------------------------------------------------------------------------ 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / / - ------- ------------------------------------------------------------------------ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.3% - ------- ------------------------------------------------------------------------ 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN - ------- ------------------------------------------------------------------------ Page 9 of 19 pages CUSIP No. 457214 10 4 13G Page 10 of 19 pages - ------- ------------------------------------------------------------------------ 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Cornelius T. Ryan - ------- ------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) / / (b) / / - ------- ------------------------------------------------------------------------ 3 SEC USE ONLY - ------- ------------------------------------------------------------------------ 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - ------------------------- ----- ------------------------------------------------ 5 SOLE VOTING POWER 0 Shares NUMBER OF ----- ------------------------------------------------ SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 2,134,615 Shares ----- ------------------------------------------------ EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 0 Shares ----- ------------------------------------------------ WITH: 8 SHARED DISPOSITIVE POWER 2,134,615 Shares - ------------------------- ----- ------------------------------------------------ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,134,615 Shares - ------- ------------------------------------------------------------------------ 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / / - ------- ------------------------------------------------------------------------ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.3% - ------- ------------------------------------------------------------------------ 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN - ------- ------------------------------------------------------------------------ Page 10 of 19 pages CUSIP No. 457214 10 4 13G Page 11 of 19 pages - ------- ------------------------------------------------------------------------ 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Alan G. Walton - ------- ------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) / / (b) / / - ------- ------------------------------------------------------------------------ 3 SEC USE ONLY - ------- ------------------------------------------------------------------------ 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - ------------------------- ----- ------------------------------------------------ 5 SOLE VOTING POWER 0 Shares NUMBER OF ----- ------------------------------------------------ SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 2,134,615 Shares ----- ------------------------------------------------ EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 0 Shares ----- ------------------------------------------------ WITH: 8 SHARED DISPOSITIVE POWER 2,134,615 Shares - ------------------------- ----- ------------------------------------------------ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,134,615 Shares - ------- ------------------------------------------------------------------------ 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / / - ------- ------------------------------------------------------------------------ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.3% - ------- ------------------------------------------------------------------------ 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN - ------- ------------------------------------------------------------------------ Page 11 of 19 pages CUSIP No. 457214 10 4 13G Page 12 of 19 pages - ------- ------------------------------------------------------------------------ 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Jonathan J. Fleming - ------- ------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) / / (b) / / - ------- ------------------------------------------------------------------------ 3 SEC USE ONLY - ------- ------------------------------------------------------------------------ 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - ------- ------------------------------------------------------------------------ 5 SOLE VOTING POWER 0 Shares NUMBER OF ----- ------------------------------------------------ SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 2,134,615 Shares ----- ------------------------------------------------ EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 0 Shares ----- ------------------------------------------------ WITH: 8 SHARED DISPOSITIVE POWER 2,134,615 Shares - ------------------------- ----- ------------------------------------------------ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,134,615 Shares - ------- ------------------------------------------------------------------------ 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / / - ------- ------------------------------------------------------------------------ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.3% - ------- ------------------------------------------------------------------------ 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN - ------- ------------------------------------------------------------------------ Page 12 of 19 pages CUSIP No. 457214 10 4 13G Page 13 of 19 pages NOTE: This Statement on Schedule 13G is being filed on behalf of: (i) Oxford Bioscience Partners II L.P., a Delaware limited partnership; (ii) Oxford Bioscience Partners (Adjunct) II L.P., a Delaware limited partnership; (iii) Oxford Bioscience Partners (GS-Adjunct) II L.P., a Delaware limited partnership; (iv) OBP Management II L.P., a Delaware limited partnership; (v) Oxford Bioscience Partners (Bermuda) II Limited Partnership, a Bermuda limited partnership; (vi) OBP Management (Bermuda) II Limited Partnership, a Bermuda limited partnership; (vii) OBP Management (Bermuda) II Ltd., a Bermuda company; (viii) Edmund M. Olivier; (ix) Cornelius T. Ryan; (x) Alan G. Walton and (xi) Jonathan J. Fleming. Item 1(a). NAME OF ISSUER: InKine Pharmaceutical Company, Inc. Item 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: Sentry Park East, 1720 Walton Road, Blue Bell, Pennsylvania 19422
ITEM 2(a) ITEM 2(b) ITEM 2(c) Citizenship or Place Name of Person Filing Address of Organization --------------------- --------- -------------------- Oxford Bioscience Partners II L.P. Oxford Bioscience Partners Delaware ("OBP II") 315 Post Road West Westport, CT 06880 Oxford Bioscience Partners Oxford Bioscience Partners Delaware (Adjunct) II L.P. ("OBP 315 Post Road West Adjunct II") Westport, CT 06880 Oxford Bioscience Partners Oxford Bioscience Partners Delaware (GS-Adjunct) II L.P. ("OBP 315 Post Road West GS-Adjunct II") Westport, CT 06880 OBP Management II L.P. ("OBP Oxford Bioscience Partners Delaware Management II") the general 315 Post Road West partner of OBP II, OBP Adjunct Westport, CT 06880 II and OBP GS-Adjunct II Oxford Bioscience Partners Richmond House Bermuda (Bermuda) II Limited Par-la-Ville Road Partnership ("OBP Bermuda II") Hamilton, Bermuda OBP Management (Bermuda) II Limited Richmond House Bermuda Partnership ("OBP Management Par-la-Ville Road Bermuda II"), the general Hamilton, Bermuda partner of OBP Bermuda II
Page 13 of 19 pages CUSIP No. 457214 10 4 13G Page 14 of 19 pages OBP Management (Bermuda) II Ltd. Richmond House Bermuda ("OBP Bermuda II Ltd."), the Par-la-Ville Road corporate general partner of Hamilton, Bermuda OBP Management Bermuda II Edmund M. Olivier, a general Oxford Bioscience Partners United States partner of OBP Management II 650 Town Center Drive and OBP Management Bermuda II Costa Mesa, California 92626 Cornelius T. Ryan, a general Oxford Bioscience Partners United States partner of OBP Management II 315 Post Road West and OBP Management Bermuda II Westport, CT 06880 Alan G. Walton, a general partner Oxford Bioscience Partners United States of OBP Management II and OBP 315 Post Road West Management Bermuda II Westport, CT 06880 Jonathan J. Fleming, a general Oxford Bioscience Partners United States partner of OBP Management II 31 St. James Avenue, Suite 905 and OBP Management Bermuda II Boston, MA 02116
Item 2(d). TITLE OF CLASS OF SECURITIES: Common Stock, $.0001 par value. Item 2(e). CUSIP NUMBER: 457 214 10 4 ------------ Item 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b), OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A: (a) / / Broker or Dealer registered under Section 15 of the Securities Exchange Act of 1934 (the "Act"). (b) / / Bank as defined in Section 3(a)(6) of the Act. (c) / / Insurance Company as defined in Section 3(a)(19) of the Act. (d) / / Investment Company registered under Section 8 of the Investment Company Act of 1940. (e) / / An Investment Adviser in accordance with Rule 13d-1(b)(i)(ii)(E) of the Act. (f) / / Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund; see Rule 13d-1(b)(1)(ii)(F) of the Act. (g) / / Parent Holding Company or control person, in accordance with Rule 13d-1(b)(ii)(G) of the Act. (h) / / A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act. (i) / / A church plan that is excluded from the definition of investment company under Section 3(c)(14) of the Investment Company Act of 1940. Page 14 of 19 pages CUSIP No. 457214 10 4 13G Page 15 of 19 pages (j) / / Group, in accordance with Rule 13d-1(b)(1)(ii)(J) of the Act. None of the above. Item 4. OWNERSHIP. (a) Amount Beneficially Owned: As of December 31, 1999, each of the following is the owner of record of the number of shares of Common Stock set forth next to his, her or its name: OBP II: 1,220,189 Shares OBP Adjunct II: 0 Shares OBP GS-Adjunct II: 0 Shares OBP Management II: 0 Shares OBP Bermuda II: 914,426 Shares OBP Management Bermuda II: 0 Shares OBP Bermuda II Ltd.: 0 Shares Mr. Olivier: 0 Shares Mr. Ryan: 0 Shares Mr. Walton: 0 Shares Mr. Fleming: 0 Shares By virtue of their relationship as affiliated limited partnerships, whose sole general partners share individual general partners, OBP II, OBP Adjunct II, OBP GS-Adjunct II and OBP Bermuda II may be deemed to share voting power and the power to direct the disposition of the shares of Common Stock which each partnership owns of record. OBP Management II (as the general partner of OBP II, OBP Adjunct II and OBP GS-Adjunct II) and OBP Management Bermuda II (as the general partner of OBP Bermuda II) may also be deemed to own beneficially the shares of OBP II, OBP Adjunct II, OBP GS-Adjunct II and OBP Bermuda II. OBP Bermuda II Ltd., as the corporate general partner of OBP Management Bermuda II, may also be deemed to own beneficially the shares of OBP II, OBP Adjunct II, OBP GS-Adjunct II and OBP Bermuda II. Messrs. Ryan, Walton, Olivier and Fleming are general partners of both OBP Management II, the general partner of OBP II, OBP Adjunct II, and OBP GS-Adjunct II, and OBP Management Bermuda II, the general partner of OBP Bermuda II. Therefore, each of Messrs. Ryan, Walton, Olivier and Fleming, the general partners of OBP Management II and OBP Management Bermuda II, may be deemed to own beneficially the shares held by OBP II and OBP Bermuda II. (b) Percent of Class: OBP II: 8.3% OBP Adjunct II: 8.3% OBP GS-Adjunct II: 8.3% OBP Management II: 8.3% OBP Bermuda II: 8.3% OBP Management Bermuda II: 8.3% OBP Bermuda II Ltd.: 8.3% Mr. Olivier: 8.3% Mr. Ryan: 8.3% Mr. Walton: 8.3% Mr. Fleming: 8.3% The foregoing percentages are calculated based on the 25,730,294 shares of Common Stock reported to be outstanding as of November 12, 1999 in the Quarterly Report on Form 10-Q of InKine Pharmaceutical Company, Inc. for the quarter ended September 30, 1999, as adjusted pursuant to Rule 13d-3 (d)(1) of the Act. (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: Page 15 of 19 pages CUSIP No. 457214 10 4 13G Page 16 of 19 pages OBP II: 0 Shares OBP Adjunct II: 0 Shares OBP GS-Adjunct II: 0 Shares OBP Management II: 0 Shares OBP Bermuda II: 0 Shares OBP Management Bermuda II: 0 Shares OBP Bermuda II Ltd.: 0 Shares Mr. Olivier: 0 Shares Mr. Ryan: 0 Shares Mr. Walton: 0 Shares Mr. Fleming: 0 Shares (ii) shared power to vote or to direct the vote: OBP II: 2,134,615 Shares OBP Adjunct II: 2,134,615 Shares OBP GS-Adjunct II: 2,134,615 Shares OBP Management II: 2,134,615 Shares OBP Bermuda II: 2,134,615 Shares OBP Management Bermuda II: 2,134,615 Shares OBP Bermuda II Ltd.: 2,134,615 Shares Mr. Olivier: 2,134,615 Shares Mr. Ryan: 2,134,615 Shares Mr. Walton: 2,134,615 Shares Mr. Fleming: 2,134,615 Shares (iii) sole power to dispose or to direct the disposition of: OBP II: 0 Shares OBP Adjunct II: 0 Shares OBP GS-Adjunct II: 0 Shares OBP Management II: 0 Shares OBP Bermuda II: 0 Shares OBP Management Bermuda II: 0 Shares OBP Bermuda II Ltd.: 0 Shares Mr. Olivier: 0 Shares Mr. Ryan: 0 Shares Mr. Walton: 0 Shares Mr. Fleming: 0 Shares (iv) shared power to dispose or to direct the disposition of: OBP II: 2,134,615 Shares OBP Adjunct II: 2,134,615 Shares OBP GS-Adjunct II: 2,134,615 Shares OBP Management II: 2,134,615 Shares OBP Bermuda II: 2,134,615 Shares OBP Management Bermuda II: 2,134,615 Shares OBP Bermuda II Ltd.: 2,134,615 Shares Mr. Olivier: 2,134,615 Shares Mr. Ryan: 2,134,615 Shares Mr. Walton: 2,134,615 Shares Mr. Fleming: 2,134,615 Shares Page 16 of 19 pages CUSIP No. 457214 10 4 13G Page 17 of 19 pages Each of OBP II, OBP Adjunct II, OBP GS-Adjunct II, OBP Management II, OBP Bermuda II, OBP Management Bermuda II, OBP Bermuda II Ltd., Mr. Olivier, Mr. Ryan, Mr. Walton and Mr. Fleming expressly disclaims beneficial ownership of any shares of Common Stock of InKine Pharmaceutical Company, Inc., except any shares held directly of record. Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: |_| Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not applicable. Item 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. Not applicable. Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. Not applicable. OBP II, OBP Adjunct II, OBP GS-Adjunct II, OBP Bermuda II, OBP Management Bermuda II, OBP Bermuda II Ltd., Mr. Olivier, Mr. Ryan, Mr. Walton and Mr. Fleming expressly disclaim membership in a "group" as defined in Rule 13d-1(b)(ii)(J) of the Act. Item 9. NOTICE OF DISSOLUTION OF GROUP. Not applicable. Item 10. CERTIFICATION. Not applicable. This statement on Schedule 13G is not filed pursuant to Rule 13d-1(b) or Rule 13d-1(c). Page 17 of 19 pages CUSIP No. 457214 10 4 13G Page 18 of 19 pages SIGNATURE After reasonable inquiry and to the best of his, her or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. We also hereby agree to file this statement jointly pursuant to the agreement set forth as EXHIBIT 1 to our initial Schedule 13G filing. Dated: February 3, 2000 OXFORD BIOSCIENCE PARTNERS II L.P. By: OBP Management II L.P., its general partner By: /S/ JONATHAN J. FLEMING --------------------------------- Jonathan J. Fleming General Partner OXFORD BIOSCIENCE PARTNERS (ADJUNCT) II L.P. By: OBP Management II L.P., its general partner By: /S/ JONATHAN J. FLEMING --------------------------------- Jonathan J. Fleming General Partner OXFORD BIOSCIENCE PARTNERS (GS - ADJUNCT) II L.P. By: OBP Management II L.P., its general partner By: /S/ JONATHAN J. FLEMING --------------------------------- Jonathan J. Fleming General Partner OBP MANAGEMENT II L.P. By: /S/ JONATHAN J. FLEMING --------------------------------- Jonathan J. Fleming General Partner OXFORD BIOSCIENCE PARTNERS (BERMUDA) II LIMITED PARTNERSHIP By: OBP Management (Bermuda) II Limited Partnership, its general partner By: /S/ JONATHAN J. FLEMING --------------------------------- Jonathan J. Fleming General Partner Page 18 of 19 pages CUSIP No. 457214 10 4 13G Page 19 of 19 pages OBP MANAGEMENT (BERMUDA) II LIMITED PARTNERSHIP By: OBP Management (Bermuda) II Ltd., its general partner By: /S/ JONATHAN J. FLEMING --------------------------------- Jonathan J. Fleming Director OBP MANAGEMENT (BERMUDA) II LTD. By: /S/ JONATHAN J. FLEMING --------------------------------- Jonathan J. Fleming Director /S/ CORNELIUS T. RYAN --------------------------------- Cornelius T. Ryan /S/ ALAN G. WALTON --------------------------------- Alan G. Walton /S/ EDMUND M. OLIVIER --------------------------------- Edmund M. Olivier /S/ JONATHAN J. FLEMING --------------------------------- Jonathan J. Fleming Page 19 of 19 pages ROSEN6178/6.924797-1 -----END PRIVACY-ENHANCED MESSAGE-----